- English language version

Table of Contents

Executive Summary

Back to French Reports Index and Shopping Cart

Back To REPORTFINDER home page and Search Engine

TABLE OF CONTENTS

EXECUTIVE SUMMARY INTRODUCTION Definitions Methodology French Economy Exchange Rates Abbreviations MARKET SIZE

Market Size And Trends, 1995-1999 Market Segmentation

Overview

Hospital Care

Overview

Public Sector

Private Sector

Nursing Unit Care

Overview

Public Sector

Private Sector

Ambulatory Care

Overview

Doctors

Doctors' Auxiliaries

Dentists

Tests

Spa

Medical Goods And Transport Preventive Care

Factors Affecting Demand

Overview

Government Policy

Introduction

Annual Budget (ONDAM)

Specific Dependence Allowance Sanctionable Medical References

Healthcare Networks And Communities Referent Practitioner

Substitution Right For Generics General Economic Environment Demographic Trends

General Health Of The Population

Innovation In Medical Treatment And Techniques Forecast Segmentation, 2000-2004

Overview

Hospital Care

Nursing Unit Care

Ambulatory Care

Overview

Doctors

Doctors' Auxiliaries

Dentists

Tests

Spa

Medical Goods And Transport

Preventive Care

MEDICAL INSURANCE

Overview

Social Security

Mutual Benefit Societies

Insurance Companies

OPPORTUNITIES FOR SUPPLIERS

Overview

Purchasing Procedures

Public Sector

Private Sector

Purchase Criteria

Introduction

Medical Equipment

Medicines

INDUSTRY STRUCTURE

Overview

Hospitals

Tests

Spas

Pharmaceuticals

Company Profiles

Assistance Publique-Hpitaux De Paris (AP-HP) Bristol-Myers Squibb Company

Overview

Bristol-Myers-Squibb Pharma France

UPSA

Cha

73

CHRU De Lille

Clinique Des Cdres

Compagnie Gnrale De Sant

Groupe Clininvest Auxigem

Groupe Eurothermes (GIE Eurothermes Dveloppement) Hoechst Marion Roussel

Johnson & Johnson Medical

Overview

DePuy

Bausch Et Lomb France

Laboratoire PASTEUR CERBA

Merck-Lipha

Overview

Groupe Merck

Groupe Lipha

Novartis Pharma

Rhne-Poulenc Rorer

Sanofi-Synthlabo

Overview

Sanofi

Synthlabo

MAGAZINES

TRADE ASSOCIATIONS

LIST OF TABLES

1. French Economic Indicators, 1996-1999

2. Healthcare Consumption In France, 1995-1999

3. Healthcare Consumption In France, By Sector, 1995-1999

4. Consumption Of Hospital Care In France, By Sector, 1995-1999

5. Number Of Hospitals And Beds In France, 1995-1999

6. Number Of Hospitals And Beds In The Public Sector In France, 1995-1999

7. Number Of Beds In Public Hospitals In France, By Type Of Care, 1995-1999

8. Number Of Beds In Public Hospitals In France, By Type Of Hospital And Type Of Care, 1998

9. Number Of Hospitals And Beds in The Private Sector In France, 1995-1999

10. Number Of Beds In Private Hospitals In France, By Type Of Care, 1995-1999

11. Number Of Beds In Private Hospitals In France, By Type Of Establishment And By Type Of Care, 1998

12. Consumption Of Nursing Unit Care In France, By Sector, 1995-1999

13. Number Of Establishments Providing Nursing Unit Care In France, 1995-1999

14. Number Of Beds In Nursing Units In France, 1995-1999

15. Consumption Of Nursing Unit Care In The Public Sector In France, 1995-1999

16. Consumption Of Nursing Unit Care In The Private Sector In France, 1995-1999

17. Consumption Of Ambulatory Care In France, 1995-1999

18. Consumption Of Ambulatory Care In France, By Type, 1995-1999

19. Consumption Of Care Provided By Doctors In France, 1995-1999

20. Number Of Doctors In France, By Type, 1995-1998

21. Consumption Of Care Provided By Doctors' Auxiliaries In France, By Type, 1995-1999

22. Number Of Doctors' Auxiliaries In France, By Type, 1995-1998

23. Consumption Of Dental Care In France, 1995-1999

24. Number Of Dentists In France, 1995-1998

25. Consumption Of Medical Tests In France, 1995-1999

26. Tests Centres In France, 1995-1999

27. Consumption Of Thermal Care Provided By Spas In France, 1995-1999

28. Consumption Of Medical Goods And Transport In France, By Type, 1995-1999

29. Consumption Of Preventive Care In France, 1995-1999

30. Healthcare Consumption, GDP And Importance Of GDP In Healthcare Consumption In France, 1995-1999

31. The French Population, By Age Group, 1995-1999

32. Life Expectancy Of Men And Of Women In France, 1950-2050 33. Main Cause Of Death In France, 1997

34. Forecast Consumption Of Healthcare In France, By Sector, 2000-2004

35. Forecast Consumption Of Hospital Care In France, By Sector, 2000-2004

36. Forecast Consumption Of Nursing Unit Care In France, By Sector, 2000-2004

37. Forecast Consumption Of Ambulatory Care In France, By Type, 2000-2004

38. Forecast Consumption Of Care Provided By Doctors In France, 2000-2004

39. Forecast Consumption Of Care Provided By Doctors' Auxiliaries In France, 2000-2004

40. Forecast Consumption Of Dental Care In France, 2000-2004

41. Forecast Consumption Of Medical Tests In France, 2000-2004 42. Forecast Consumption Of Thermal Care Provided By Spas In France, 2000-2004

43. Forecast Consumption Of Medical Goods And Transport In France, By Type, 2000-2004

44. Forecast Consumption Of Preventive Care In France, 2000-2004

45. Funding Of Healthcare In France, By Type Of Organisation, 1995-1999

46. Proportional Importance Of Sources Of Funding Of Healthcare In France, By Sector, 1999

47. French Social Security Funding Of Healthcare Expenditure, By Type Of Expenditure, 1995-1999

48. Deficit Of The General Scheme Of The French Social Security, 1995-1999

49. Mutual Benefit Societies' Funding Of Healthcare Expenditure, By Type Of Expenditure, 1995-1999

50. Insurance Companies Funding Of Healthcare Expenditure, By Type Of Expenditure, 1995-1999

51. Bed Portfolio Of Assistance Publique-Hpitaux De Paris, By Type Of Care, 1993-1997

52. Major Equipment Of Assistance Public-Hopitaux De Paris, By Type Of Equipment, 1997

53. Notified Investment Of Assistance Publique-Hopitaux De Paris, 1993-1997

54. Sales Of Hoechst Marion Roussel In France, By Activity, 1998

55. Financial Summary Of Laboratoire PASTEUR CERBA, 1994-1998 56. Consolidated Accounts Of Merck-Lipha, 1996-1998

57. Consolidated International Turnover Of Merck-Lipha, By Activity, 1996-1998

58. Consolidated International Accounts Of Groupe Lipha, 1996-1998

59. Turnover Of Groupe Lipha, By Activity, 1998

60. Consolidated Sales Of The Healthcare Division Of Novartis, By Division, 1997 & 1998

61. Turnover Of Rhne-Poulenc Rorer, By Activity, 1998

62. Consolidated Accounts Of Sanofi, 1995-1998

63. Consolidated Accounts Of Synthlabo, 1995-1998

Back to Top

EXECUTIVE SUMMARY

MSI projects that healthcare consumption in France will increase by 2 percent in 1999 to reach a value of FF771.9 billion (euro116.9 billion). The overall value of the market has increased by 11 percent since 1995.

Hospital care consumption in France is projected to

increase by 1 percent in 1999 and will continue to account for the largest part of the French healthcare market in value terms. This sector has been affected by rationalisation and restructuring policies undertaken by the government to limit its spending.

Ambulatory care is the second most important segment within the French healthcare market, representing some 27 percent of the total healthcare consumption in 1998. MSI project that French consumption of ambulatory care will increase by 2 percent in 1999 as a result of measures taken by the government to restrict expenditure.

MSI believe that the main factors that affect the French healthcare market include the following:

* government policy

* general economic environment

* demographic trends

* general health of the population

* innovation in medical treatment and techniques

French healthcare consumption is forecast to increase by 1 percent

in 2000 to reach a value of FF781.0 billion (euro118.3 billion).

MSI believe that the French market for healthcare will increase between 2000 and 2001 and then start to decline gradually in real terms as the pressure from the government to reduce spending will intensify.

Medical insurance is provided by three types of

organisations in France. The social security system will fund some 73.7 percent of the healthcare expenditure and mutual benefit societies and insurance companies will fund a further 7.3 percent and 3.2 percent respectively in 1999. Some 13.4 percent will be self-funded, whilst the remaining 2.4 percent will by provided by local authorities and contingency funds.

Text © 1999 MSI

Back to Top

Back ToREPORTFINDER HOME PAGE

Ariadne - working together with our customers to enhance productivity and increase knowledge

© 2000 www.the-list.co.uk Ariadne

Last updated by Jacob van Eldik 20th February 2000